Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ0113 in Early-stage Parkinson's Disease
NCT06596005Phase 2Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TJ0113 in Parkinson's disease (PD), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Sep 2024; status: completed.
02
Drugs
TJ0113
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06596005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06596005.